Chagas disease: comments on the 2018 PAHO Guidelines for diagnosis and management

J Travel Med. 2019 Oct 14;26(7):taz060. doi: 10.1093/jtm/taz060.

Abstract

Background: Chagas disease, or American trypanosomiasis, is a protozoan infectious disease endemic throughout most of the Americas, caused by the trypanosome, Trypanosoma cruzi, and mainly transmitted to humans by reduviid or kissing bugs. Some progress has been achieved in control of the disease mainly in endemic areas, but migration flows have acted as drivers for the emergence of the disease mainly in non-endemic areas of Europe and North America. Most imported cases of Chagas disease in Europe are reported in migrants from highly endemic areas of countries such as Bolivia and Paraguay, and reports of Chagas disease in travellers are extremely rare.

Methods: Pan American Health Organization (PAHO) recently updated their guidelines on the diagnosis and management of Chagas. These guidelines and their applicability to migrants and travellers are reviewed.

Results: PAHO recommends the use of two serological tests for diagnosis of chronic infection (allowing for the use of a single sensitive test followed by confirmation in special settings such as the screening of potential blood donors). The indication for specific trypanocidal treatment of acute infections, children and women of child-bearing age remains as before, with either benznidazole or nifurtimox being the treatment of choice. For chronic infection with/without organ damage, treatment recommendations are less well defined. Although treatment is generally not recommended in patients with visceral involvement, decisions regarding treatment need to be tailored to the individual. Either benznidazole or nifurtimox may be used for initial treatment.

Conclusions: The recent PAHO Guidelines provide a framework to aid the diagnosis and management of this infection, but several aspects such as the underdiagnosis of infections, the multidisciplinary approach to patient management, the investigation of novel biomarkers of disease progression/response to treatment and the development of new treatment strategies are areas which should be further strengthened.

Keywords: Chagas disease; Immigration; Travel; Trypanosoma cruzi.

Publication types

  • Review

MeSH terms

  • Antiparasitic Agents / therapeutic use*
  • Chagas Disease / diagnosis*
  • Chagas Disease / drug therapy
  • Chagas Disease / epidemiology
  • Disease Management*
  • Global Health
  • Humans
  • Incidence
  • Pan American Health Organization
  • Practice Guidelines as Topic*
  • Travel*

Substances

  • Antiparasitic Agents